Hemimandibular elongation: treatment and long-term follow-up.
نویسندگان
چکیده
OBJECTIVE To study long-term changes in the mandibular asymmetry of patients with hemimandibular elongation (HE) treated with two-phase surgical orthodontic approach. DESIGN Descriptive clinical study. SETTING AND SAMPLE POPULATION Private practice setting. Seven (six females) out of 47 diagnosed and treated patients for severe mandibular asymmetry were included with the following criteria: diagnosis of HE based on clinical, radiological and single photon emission computed tomography bone scintigraphic studies, good quality orthopantomograms (OPT) available at six time-points, two-phase surgical treatment (high condylectomy, HC, and orthognathic surgery, OS) and measurements of maximal mouth opening (MMO) available. METHOD Mandibular ramus height and corpus length were measured on OPTs at six time-points. Ratios between the affected/non-affected sides were calculated. RESULTS All patients had progression of mandibular asymmetry before any operation, which finding together with the scintigraphy resulted to the decision to perform HC. Thereafter ramus and corpus asymmetry decreased compared with the initial measurements. After OS, stable symmetry of corpuses and alignment of skeletal and dental midlines were obtained. MMO reduced on average 50% after HC, regained 20% after OS and recovered almost totally at the last follow-up. CONCLUSIONS High condylectomy to stop excessive growth and OS to correct facial asymmetry is considered successful and necessary treatment for patients with HE. MMO can well recover after surgical traumas. Orthodontists should consider mandibular asymmetry as abnormal and need for surgical treatment if asymmetry is progressive and the ratio between affected/non-affected sides approaches 10%.
منابع مشابه
Hemimandibular Elongation: a Case Report with a 7- Year Follow-up
One of the many growth anomalies that affect the mandibular condyle is hemimandibular elongation without any condylar hyperplasia. Condylar growth patterns can be evaluated by serial clinical comparisons, cephalometric tracings and bone scanning with technetium 99m phosphate. However, no ideal method has been found to assess whether condylar overgrowth is “inactive”. Therapy is guided by the pa...
متن کاملLong term follow up of recurrent uterine cervical cancer: A Case Report
Background and Aim: Carcinoma of the uterine cervix is a significant cause of mortality because of malignancy in women. Radiotherapy is a major treatment modality for invasive cervical cancer with good treatment outcome in early-stage patients. However, substantial treatment failures still occur in the advanced-stage patients. In this case report a long term follow up of a 58 years old woman wi...
متن کاملRevision Fixation of Distal Humerus Fracture Nonunions in Older Age Patients with Poor Bone Quality or Bone Loss – Is This Viable as a Long-term Treatment Option?
Background: The purpose of this retrospective study was to analyze the long-term results of revision ORIF, jointcontracture release, and autogenous bone-grafting in the treatment of distal humerus frac-ture nonunions in older agedpatients with poor bone quality or bone loss who would have been candidates for total elbow arthroplasty.Methods: Seven patients (average age at inde...
متن کاملLong Term Follow up Study on a Large Group of Patients with Congenital Factor XIII Deficiency Treated Prophylactically with Fibrogammin P®
Factor XIII deficiency (FXIIID) is an extremely rare hemorrhagic disorder with a prevalence of 1/3-5 million. Management of disease is performed by fresh frozen plasma (FFP), Cryoprecipitate (CP) or FXIII concentrate (Fibrogammin P®). Our objective was to assess safety and effectiveness of Fibrogammin P® in patients with FXIIID. For this purpose we designed this long-term follow up study on a l...
متن کاملLong Term Follow up Study on a Large Group of Patients with Congenital Factor XIII Deficiency Treated Prophylactically with Fibrogammin P®
Factor XIII deficiency (FXIIID) is an extremely rare hemorrhagic disorder with a prevalence of 1/3-5 million. Management of disease is performed by fresh frozen plasma (FFP), Cryoprecipitate (CP) or FXIII concentrate (Fibrogammin P®). Our objective was to assess safety and effectiveness of Fibrogammin P® in patients with FXIIID. For this purpose we designed this long-term follow up study on a l...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Orthodontics & craniofacial research
دوره 11 3 شماره
صفحات -
تاریخ انتشار 2008